Aillis, Inc.
PrivateLast Round
Series D
Mar 27, 2024
Total Funding Raised
$81.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aillis, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series D round in March 2024.
Aillis, Inc. is a Japanese medical technology company that develops and manufactures AI-powered medical devices, including its flagship influenza diagnostic system, nodoca.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aillis, Inc. Comparables
Compare Aillis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AI Medical Service Inc. | 69% | |
| Fujifilm Holdings Corporation | 67% | |
| LPIXEL Inc. | 66% |
For institutional investors. Book with your work email.
Aillis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 27, 2024 | ||||
| Series C | Jun 29, 2022 | ||||
| Series B | Aug 5, 2020 | ||||
| Series B | May 7, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aillis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series B |
| Shionogi & Co. | Series B |
| Nanto Bank | Series D |
| CEJ Capital | Series C |
| Monex Ventures | Series D |
| QB Capital | Series B |
| Beyond Next Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 31% MoM, reaching 8K.
- Jun 8, 2026
Open roles increased to 8, 2.4x the trailing average.
For institutional investors. Book with your work email.
Aillis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aillis, Inc.'s valuation, stock price, and market status.
Is Aillis, Inc. a public or private company?
Aillis, Inc. is a private company.
What is the current stock price of Aillis, Inc.?
Aillis, Inc. is a private company, so its shares have no public market price. Caplight tracks Aillis, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aillis, Inc. worth (valuation)?
Valuation information for Aillis, Inc. is not publicly available.
Can I buy Aillis, Inc. stock?
Aillis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aillis, Inc.'s last funding round?
Aillis, Inc.'s most recent funding round was Series D on March 27, 2024.
Who are the main investors in Aillis, Inc.?
Key investors in Aillis, Inc. include Keio Innovation Initiative, Shionogi & Co., Nanto Bank, CEJ Capital, Monex Ventures.
Will Aillis, Inc. IPO soon?
No public IPO plans have been announced for Aillis, Inc..
How can I track Aillis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Aillis, Inc.'s shares on secondary markets.